227 related articles for article (PubMed ID: 12163261)
1. A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses.
Jegerlehner A; Tissot A; Lechner F; Sebbel P; Erdmann I; Kündig T; Bächi T; Storni T; Jennings G; Pumpens P; Renner WA; Bachmann MF
Vaccine; 2002 Aug; 20(25-26):3104-12. PubMed ID: 12163261
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
3. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
4. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
5. Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.
Sominskaya I; Skrastina D; Dislers A; Vasiljev D; Mihailova M; Ose V; Dreilina D; Pumpens P
Clin Vaccine Immunol; 2010 Jun; 17(6):1027-33. PubMed ID: 20410327
[TBL] [Abstract][Full Text] [Related]
6. Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.
Netter HJ; Macnaughton TB; Woo WP; Tindle R; Gowans EJ
J Virol; 2001 Mar; 75(5):2130-41. PubMed ID: 11160717
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis nucleocapsid as a vaccine carrier moiety.
Milich DR; Peterson DL; Zheng J; Hughes JL; Wirtz R; Schödel F
Ann N Y Acad Sci; 1995 May; 754():187-201. PubMed ID: 7542855
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein.
Kingston NJ; Kurtovic L; Walsh R; Joe C; Lovrecz G; Locarnini S; Beeson JG; Netter HJ
Vaccine; 2019 Mar; 37(12):1674-1684. PubMed ID: 30773400
[TBL] [Abstract][Full Text] [Related]
10. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen.
Ulrich R; Borisova GP; Gren E; Berzin I; Pumpen P; Eckert R; Ose V; Siakkou H; Gren EJ; von Baehr R
Arch Virol; 1992; 126(1-4):321-8. PubMed ID: 1381912
[TBL] [Abstract][Full Text] [Related]
12. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
Schödel F; Peterson D; Hughes J; Milich DR
Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
[TBL] [Abstract][Full Text] [Related]
13. Whole-Chain Tick Saliva Proteins Presented on Hepatitis B Virus Capsid-Like Particles Induce High-Titered Antibodies with Neutralizing Potential.
Kolb P; Wallich R; Nassal M
PLoS One; 2015; 10(9):e0136180. PubMed ID: 26352137
[TBL] [Abstract][Full Text] [Related]
14. A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles.
Blokhina EA; Kuprianov VV; Stepanova LA; Tsybalova LM; Kiselev OI; Ravin NV; Skryabin KG
Virology; 2013 Jan; 435(2):293-300. PubMed ID: 23062739
[TBL] [Abstract][Full Text] [Related]
15. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
16. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.
Huret C; Desjardins D; Miyalou M; Levacher B; Amadoudji Zin M; Bonduelle O; Combadière B; Dalba C; Klatzmann D; Bellier B
Vaccine; 2013 Mar; 31(11):1540-7. PubMed ID: 22634300
[TBL] [Abstract][Full Text] [Related]
17. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope.
Milich DR; Hughes JL; McLachlan A; Thornton GB; Moriarty A
Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1610-4. PubMed ID: 2449694
[TBL] [Abstract][Full Text] [Related]
19. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
Tsybalova LM; Stepanova LA; Kuprianov VV; Blokhina EA; Potapchuk MV; Korotkov AV; Gorshkov AN; Kasyanenko MA; Ravin NV; Kiselev OI
Vaccine; 2015 Jun; 33(29):3398-406. PubMed ID: 25976545
[TBL] [Abstract][Full Text] [Related]
20. Major Immunodominant Region of Hepatitis B Virus Core Antigen as a Delivery Vector to Improve the Immunogenicity of the Fusion Antigen ROP2-SAG1 Multiepitope from Toxoplasma gondii in Mice.
Wang W; Feng F; Lv J; Xie Z; Chen J; Zhang L; Li W
Viral Immunol; 2017 Sep; 30(7):508-515. PubMed ID: 28436740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
